Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice. 1979

I Malavé, and I Blanca, and H Fuji

The growth of the Lewis lung carcinoma (3LL) was studied in syngeneic C57BL/6 mice inoculated sc with similar numbers of tumor cells in either the flank or the hind footpad (fp). After injection of small numbers of 3LL cells, the incidence of tumors was lower in the flank than in the fp. However, after a successful 3LL transplant, tumors in the flank progressed faster than those in the fp, as evidenced by the early metastatic dissemination to the lungs and the shorter survival of the hosts. Local adoptive transfer tests demonstrated the early appearance of suppressor cell activity in spleens from mice bearing tumors in the flank. Adult thymectomy as well as treatement with antithymocyte serum after the tumor transplant inhibited the growth of a flank tumor but did not modify significantly that of an fp tumor. Thus variations in the site of a subcutaneous tumor implant resulted in differences in tumor development that appeared to depend on the characteristics of the immune response elicited by the inoculum.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

I Malavé, and I Blanca, and H Fuji
January 1994, Proceedings of the Western Pharmacology Society,
I Malavé, and I Blanca, and H Fuji
January 1985, Cancer immunology, immunotherapy : CII,
I Malavé, and I Blanca, and H Fuji
December 1979, The Australian journal of experimental biology and medical science,
I Malavé, and I Blanca, and H Fuji
December 1987, Journal of leukocyte biology,
I Malavé, and I Blanca, and H Fuji
October 1979, Proceedings of the National Academy of Sciences of the United States of America,
I Malavé, and I Blanca, and H Fuji
December 1986, Journal of the National Cancer Institute,
Copied contents to your clipboard!